1-4 of 4
David J. Inwards
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy

Jessica F. Burlile, Kelsey M. Frechette, William G. Breen, Steven R. Hwang, Alexandra S. Higgins, Adrienne N. Nedved, William S. Harmsen, Sydney D. Pulsipher, Thomas E. Witzig, Ivana N. Micallef, Bradford S. Hoppe, Thomas M. Habermann, Gita Thanarajasingam, Patrick B. Johnston, David J. Inwards, N. Nora Bennani, Jennifer L. Peterson, Bradley J. Stish, William G. Rule, Stephen M. Ansell, Scott C. Lester
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1250–1257.
https://doi.org/10.1182/bloodadvances.2023011533
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie, Parv Chapani, Shaoying Li, L. Jeffrey Medeiros, Michael Wang, Jonathon B. Cohen, Michael Churnetski, Brian T. Hill, Yazeed Sawalha, Francisco J. Hernandez-Ilizaliturri, Shalin Kothari, Julie M. Vose, Martin Bast, Timothy Fenske, Swapna Narayana Rao Gari, Kami J. Maddocks, David Bond, Veronika Bachanova, Bhaskar Kolla, Julio Chavez, Bijal Shah, Frederick Lansigan, Timothy Burns, Alexandra M. Donovan, Nina Wagner-Johnston, Marcus Messmer, Amitkumar Mehta, Jennifer K. Anderson, Nishitha Reddy, Alexandra E. Kovach, Daniel J. Landsburg, Martha Glenn, David J. Inwards, Kay Ristow, Reem Karmali, Jason B. Kaplan, Paolo F. Caimi, Saurabh Rajguru, Andrew Evens, Andreas Klein, Elvira Umyarova, Bhargavi Pulluri, Jennifer E. Amengual, Jennifer K. Lue, Catherine Diefenbach, Richard I. Fisher, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7393–7401.
https://doi.org/10.1182/bloodadvances.2023010757
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

Clinical Trials & Observations
Alessia Castellino, Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Andrew L. Feldman, Sergei I. Syrbu, Thomas M. Habermann, Jonas Paludo, David J. Inwards, Thomas E. Witzig, Stephen M. Ansell, Cristine Allmer, Susan L. Slager, Jonathon B. Cohen, Peter Martin, James R. Cerhan, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1350–1360.
https://doi.org/10.1182/bloodadvances.2021005715
Published: 2022
Includes: Supplemental data